Cytek Biosciences, Inc. (CTKB)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
Scientific & Technical Instruments	201.49M	200.45M	193.02M	164.04M	127.95M
Total	201.49M	200.45M	193.02M	164.04M	127.95M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2011	FY 2010	FY 2009
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009
United States	95.25M	92.61M	102.09M	94.59M	72.72M
EMEA	55.88M	62.34M	53.18M	43.96M	36.97M
APAC	41.08M	35.77M	31.60M	22.52M	16.08M
Other	9.28M	9.73M	6.15M	2.96M	2.18M
Total	201.49M	200.45M	193.02M	164.04M	127.95M

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 28, 2026

Data Sources Report a data error